CURX Stock Chart & Stats
$0.19
>-$0.01(-2.61%)
At close: 4:00 PM EDT
$0.19
>-$0.01(-2.61%)
Day’s Range― - ―
52-Week Range$0.18 - $9.18
Previous Close$0.18
Volume113.47K
Average Volume (3M)2.97M
Market Cap
$5.42M
Enterprise Value$5.79M
Total Cash (Recent Filing)$4.02M
Total Debt (Recent Filing)$311.00K
Price to Earnings (P/E)―
Beta0.57
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding28,364,813
10 Day Avg. Volume777,524
30 Day Avg. Volume2,968,060
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.75
Price to Sales (P/S)0.00
P/FCF Ratio-0.80
Enterprise Value/Market Cap1.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-165.14
Enterprise Value/Ebitda-1.96
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Curanex Pharmaceuticals Inc. News
CURX FAQ
What was Curanex Pharmaceuticals Inc.’s price range in the past 12 months?
Curanex Pharmaceuticals Inc. lowest stock price was $0.18 and its highest was $9.18 in the past 12 months.
What is Curanex Pharmaceuticals Inc.’s market cap?
Curanex Pharmaceuticals Inc.’s market cap is $5.42M.
When is Curanex Pharmaceuticals Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Curanex Pharmaceuticals Inc.’s earnings last quarter?
Currently, no data Available
Is Curanex Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Curanex Pharmaceuticals Inc.’s price is currently Overvalued.
Does Curanex Pharmaceuticals Inc. pay dividends?
Curanex Pharmaceuticals Inc. does not currently pay dividends.
What is Curanex Pharmaceuticals Inc.’s EPS estimate?
Curanex Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Curanex Pharmaceuticals Inc. have?
Curanex Pharmaceuticals Inc. has 28,364,813 shares outstanding.
What happened to Curanex Pharmaceuticals Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Curanex Pharmaceuticals Inc.?
Currently, no hedge funds are holding shares in CURX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Curanex Pharmaceuticals Inc.
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Technical Analysis
Ownership Overview
―
Insiders
0.07% Mutual Funds
0.25% Other Institutional Investors
99.68% Public Companies and
Individual Investors